LUCIUS 卢修斯 奥拉帕利 Olaparib卵巢癌、乳腺癌

奥拉帕利

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Olaparib

老挝国家食药监局批准上市
老挝国家药检所检测认证

卵巢癌、乳腺癌

Compositior:Each tabletcontains: Olaparib ....... 150m

Indicaliou:
uc Olap is a poly (ADP-ribose ]polymerase (PARP) inhibit

LUCIUS

.Ovarian tancer
For the maintenance treatment ef sl.n

PHARMACEUTICALS

BR.CA-mutateds5ne Or
adyancedenithelial ouseian fallocian tu
primary pentoneal cancer who se in somlns oa
cancer hho are in comiplete or parttal

eetof adult patiante kt

LUCIOLAP®

For thetreatment of adl oo
de leterioue .pn. cpatients writh A.
deleterious pBRCAm uen. r
w bo have heen trealed gauve metastar

FDA批准

.rancreahic cancer
For tte mainfenance treat

film-coated tablets
150 mg

etlnent of adult patients winh d
adenocarcinotea shon

olaparib

e piztinum-based cheroth
For the treatment of adult pafients
m-pased chertolnerapy regimen
en gor somatic homoloco
patients with deleterious or suspected

120

The recommended n

film-coated tablets

twice dailo wileis s0 mg laket orai
Kcep medicine out of the reach of Child

权威认证

rfegnancy and Lactedion n
PLEASE SEE PACKAGE IN
of Children. Do not admnuns
Manufactured and Marketed by
LUCIUS

Thonemang villane Karthany distrid

Vientiane ean

www.lucius.la
amiag . 1o be solo by retall on prescription
o Tegistered physicians only and ac dlrsetad
etail on nrasorieto

口碑质量

适应症:
适用于铂敏感的复发性上皮性卵巢癌、输卵管癌或原发性腹
膜癌成人患者在含铂化疗达到完全缓解或部分缓解后的维持

治疗。

推荐剂量:

1、每日口服两次,每次300mg。
2、患者应在含铂化疗结束后的8周内开始本品治疗,持续治疗
直至疾病进展或发生不可接受的毒性反应。
3、整片吞服,不要咀嚼药片,进餐和空腹均可使用。